Findings

What do systematic reviews say?

8 questions · 8 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 37.5%GRADE not reported 0 · 0%Very low 0 · 0%Low 5 · 62.5%Moderate 0 · 0%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Reference pricing policy vs no reference pricing · Healthcare utilisation
  Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
Direct match · question page
- Reference pricing policy vs no reference pricing · Insurer's drug expenditures one year after the transition period
  Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low
Direct match · question page
- Reference pricing policy vs no reference pricing · Insurer's cumulative drug expenditures one year after the transition period
  Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low
Direct match · question page
- Reference pricing policy vs no reference pricing · Drug use one year after the transition period
  Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low
Direct match · question page
- Reference pricing policy vs no reference pricing · Health outcomes
  Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Reference pricing policy vs no reference pricing

Insurer's cumulative drug expenditures one year after the transition period · Patients with drug insurance

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Reference pricing policy vs no reference pricing

Insurer's drug expenditures one year after the transition period · Patients with drug insurance

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Reference pricing policy vs no reference pricing

Drug use · Patients with drug insurance

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Reference pricing policy vs no reference pricing

Healthcare utilisation · Patients with drug insurance

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Reference pricing policy vs no reference pricing

Health outcomes · Patients with drug insurance

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Reference pricing policy vs no reference pricing

Adverse events · Patients with drug insurance

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Index pricing vs no index pricing

Drug use · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Index pricing vs no index pricing

Drug prices · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…

1 finding from 1 review

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low